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Abstract
Stress signals cause abnormal proteins to accumulate in the endoplasmic reticulum (ER). Such stress is known as ER stress,
which has been suggested to be involved in neurodegenerative diseases, diabetes, obesity and cancer. ER stress activates
the unfolded protein response (UPR) to reduce levels of abnormal proteins by inducing the production of chaperon proteins
such as GRP78, and to attenuate translation through the phosphorylation of eIF2a. However, excessive stress leads to
apoptosis by generating transcription factors such as CHOP. Casein kinase 2 (CK2) is a serine/threonine kinase involved in
regulating neoplasia, cell survival and viral infections. In the present study, we investigated a possible linkage between CK2
and ER stress using mouse primary cultured glial cells. 4,5,6,7-tetrabromobenzotriazole (TBB), a CK2-specific inhibitor,
attenuated ER stress-induced XBP-1 splicing and subsequent induction of GRP78 expression, but was ineffective against ER
stress-induced eIF2a phosphorylation and CHOP expression. Similar results were obtained when endogenous CK2
expression was knocked-down by siRNA. Immunohistochemical analysis suggested that CK2 was present at the ER. These
results indicate CK2 to be linked with UPR and to resist ER stress by activating the XBP-1-GRP78 arm of UPR.
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Introduction
Stress signals, which impair endoplasmic reticulum (ER)
function, result in the accumulation of unfolded proteins. Such
an accumulation causes ER stress. Increasing evidence has
suggested that ER stress is involved in several types of disease
including neurodegenerative disorders, diabetes, obesity and
cancer. It is thus important to elucidate the precise mechanisms
of ER stress-mediated activation of the unfolded protein response
(UPR).
When exposed to ER stress, cells activate several UPR
pathways. These responses include 1) increasing the folding
capacity of unfolded proteins by releasing chaperon proteins, 2)
inhibiting general protein translation to stop the production of
unfolded proteins, and 3) promoting the degradation of unfolded
proteins [1–3]. However, when exposed to severe stress, cells
activate apoptotic pathways. As components responsible for the
activation of UPR, several ER stress-sensing proteins, which reside
in the ER, have been identified: i.e. inositol-requiring protein-1
(IRE1), PKR-like ER kinase (PERK), and activating transcription
factor 6 (ATF6). Activation of these stress-sensors eventually
transmits stress signals to the nucleus [4]. For example, activation
of IRE1 induces X-box binding protein 1 (XBP-1) mRNA splicing
[5]. The spliced form of XBP-1 then functions as a transcription
factor for ER stress-related genes such as the glucose-regulated
protein 78 (GRP78) gene [6]. GRP78 functions as a chaperon
protein, involved in protein folding. The activation of PERK
increases phosphorylation of the a subunit of eukaryotic trans-
lation initiation factor 2 (eIF2), resulting in translational repression
[7,8]. Meanwhile, the increase in eIF2 phosphorylation, paradox-
ically activates the CCAAT/enhancer-binding protein homolo-
gous protein (CHOP) promoter and results in production of
CHOP, an apoptotic transcription factor [9].
Protein kinase CK2 is a serine/threonine protein kinase
composed of two catalytic a, a’ subunits and two regulatory
b subunits [10]. CK2 is involved in protecting cells from various
kinds of stress. For example, UV irradiation increases CK2-
dependent phosphorylation of p53, which would decrease the
proapoptotic function of p53 [11]. Heat shock stress has been
shown to re-localize CK2 subunits to specific nuclear regions [12].
Furthermore, stress-activating agents such as anisomycin, arsenite,
and tumor necrosis factor-a (TNF-a) stimulate CK2 activity
through p38 MAP kinase [13]. These observations suggest that
CK2 plays an important role in protecting cells against such stress.
However, it is unknown whether CK2 is involved in protecting
against type of stress, which perturb ER function (ER stress). In the
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e40144present study, therefore, we investigated the possible role of CK2
under ER stress.
Results
CK2 Regulates ER Stress-induced Activation of the XBP-1-
GRP78 Arm of UPR
UPR was induced upon treatment with ER stress-inducing
reagent in the glial cells [14–16]. Glial cells especially astrocyte
have unique property to tolerate against ischemic or hypoxic
stress, which lead to ER stress. One of the responsive mechanisms
of the resistance against glial cell death would be mediated through
the old astrocyte specifically induced substance (OASIS) [17]. In
the present study, we did not observe prominent glial cell death as
far as we can ascertain in the present condition. To evaluate the
role of CK2 in the ER stress-induced activation of UPR, we
exposed glial cells to ER stress-inducing reagents (tunicamycin:
Tm, which interferes with protein glycosylation, and thapsigargin:
Tg, which interferes with the Ca
2+ balance) along with the CK2-
specific inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) [18], and
examined the level of GRP78. Consistent with a previous report
[14], the expression of GRP78 was induced by the reagents in
primary cultured glial cells (Fig. 1). TBB treatment alone did not
affect GRP78 levels (Fig. 1). However, the expression of GRP78
was inhibited by pre-treatment with TBB (Fig. 1). The inhibitory
effects of TBB were observed at both the mRNA and protein levels
(Fig. 1AB). To further confirm the contribution of CK2 to ER
stress-induced GRP78 expression, we next knocked down endog-
enous CK2 expression by transfecting CK2 siRNA. The CK2
siRNA but not control siRNA markedly reduced the endogenous
level of CK2 (Fig. 2A). Therefore, we next analyzed the expression
of GRP78 under these conditions. Again, knocking down CK2
alone did not affect GRP78 levels (Fig. 2B-D). However, we
observed significant inhibition of ER stress-induced expression of
GRP78 at both the mRNA and protein levels on knocking down
CK2 (Fig. 2B-D). Therefore, the results suggest CK2 to be
involved in the ER stress-induced expression of GRP78.
As we found that CK2 regulates GRP78 levels via the mRNA,
we next focused on the upstream regulators of GRP78.
Accordingly we investigated the role of CK2 in ER stress-induced
splicing of XBP-1, an upstream regulator of GRP78 [6]. We
treated glial cells with a CK2 inhibitor (TBB) and analyzed the
level of XBP-1 splicing. We did not observe any changes in XBP-1
splicing on treatment with TBB alone, but observed significant
inhibition of ER stress-induced XBP-1 splicing by TBB (Fig. 3AB).
Conversely, the total amount of XBP-1 (spliced and unspliced
XBP-1) was not changed by TBB, suggesting that CK2 did not
affect the XBP-1 transcript (Fig. 3C). To further confirm these
results, we next knocked down endogenous CK2 expression by
transfecting CK2 siRNA and analyzed ER stress-induced XBP-1
splicing. Consistent with the results obtained using TBB, we
observed inhibition of ER stress-induced XBP-1 splicing on
knocking down CK2 (Fig. 4). Overall, from these observations, it is
suggested that CK2 plays a key role in the ER stress-induced
activation of the XBP-1-GRP78 arm of UPR.
CK2 may not be Involved in Regulation of ER Stress-
induced Activation of the eIF2a-CHOP Arm of UPR
We next investigated the possible involvement of CK2 in
another important arm of UPR, the eIF2a-CHOP pathway. We
Figure 1. A CK2 inhibitor inhibited ER stress-induced GRP78 expression. 4,5,6,7-tetrabromobenzotriazole (TBB) inhibited GRP78 expression
at the mRNA and protein levels. (A) Primary cultured glial cells were pre-treated with 4,5,6,7-tetrabromobenzotriazole (TBB: 5 mM) for 3 h and then
treated with tunicamycin (Tm: 0.01 mg/mL) or thapsigargin (Tg: 0.01 mM) for 6 h. RT-PCR was performed using specific primers for each mRNA. n=4/
group *p,0.05 compared with ER stress (Tm, Tg) alone. (B) Primary cultured glial cells were pre-treated with 4,5,6,7-tetrabromobenzotriazole (TBB:
5 mM) for 3 h, then treated with tunicamycin (Tm: 0.01 mg/mL) or thapsigargin (Tg: 0.01 mM) for 18 h, and subjected to Western blotting. n=3/group
*p,0.05 compared with ER stress (Tm) alone. Results are expressed as the means 6 S.E.
doi:10.1371/journal.pone.0040144.g001
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phosphorylation of eIF2a, a downstream regulator of ER stress
sensor protein PERK. As indicated in figure 5A, we observed no
changes in the phosphorylation of eIF2a. To further confirm the
results, we next investigated the effect of TBB on ER stress-
induced expression of CHOP, a transcription factor known to be
regulated through eIF2a [9]. We used TBB along with an ER
stress-inducing reagent and analyzed the level of CHOP. As
expected, we did not find any changes in CHOP at the mRNA or
protein level after the treatment with TBB (Fig. 5BC). These
findings indicate that CK2 would not affect ER stress-induced
activation of the eIF2a-CHOP arm of UPR.
To further analyze possible involvement of CK2 on ATF6
pathway, the effect of TBB on ER stress-induced ATF6 cleavage
was analyzed in SH-SY5Y cell line. Similarly with the result
obtained from glial cells, we observed significant inhibition of ER
stress-induced induction of GRP78 when treated with TBB
(Fig. 6A). However, we did not observe inhibition of ER stress-
induced ATF6 cleavage by TBB (Fig. 6B-D). Therefore, the results
suggest that CK2 would not affect ER stress-induced induction of
ATF6 cleavage.
Expression and Subcellular Distribution of CK2
As we found that CK2 would contribute to ER stress-induced
activation of UPR via the XBP-1-GRP78 pathway, we next
investigated whether the expression of CK2 would be affected by
ER stress. We used ER stress-inducing reagents (tunicamycin: Tm
and thapsigargin: Tg) and analyzed the level of CK2 protein.
Although both reagents markedly increased GRP78 levels, we did
not observe the expression of CK2 (Fig. 7). The results suggest that
ER stress would not affect the level of CK2. CK2 would therefore
function to regulate XBP-1-GRP78 signaling by regulating its
activity.
As CK2 can regulate an ER stress-activated UPR signal, the
subcellular distribution of CK2 was analyzed by immunohisto-
chemistry. We stained the ER with anti-KDEL antibody (ER
marker) along with anti-CK2 antibody. Consistent with a previous
report [19], the staining of CK2 merged with the ER marker
(Fig. 8). The results suggest that CK2 exists in the ER in the glial
cells.
Figure 2. Knocking down CK2 inhibited ER stress-induced GRP78 expression. (A) Western blot analysis of endogenous CK2a expression in
lysates of nontransfected cells (NT) and cells transfected with (short interfering RNA) siRNAs (75 nM) directed at CK2 or the control sequence. CK2
siRNA reduced the expression of CK2 compared with NT or control siRNA. (B) CK2 siRNA decreased ER stress-induced GRP78 expression compared
with control siRNA. Primary cultured glial cells were transfected with 75 nM siRNA and treated with tunicamycin (Tm: 0.01 mg/mL) for 4 h. RT-PCR was
then performed. n=3/group (C, D) CK2 siRNA decreased ER stress-induced GRP78 expression compared with control siRNA. Primary cultured glial
cells were transfected with 75 nM siRNA, treated with tunicamycin (Tm: 0.01 mg/mL) or thapsigargin (Tg: 0.01 mM) for 18 h, and subjected to Western
blotting. n=3–4/group *p,0.05, **p,0.01 compared with control siRNA. Results are expressed as the means 6 S.E.
doi:10.1371/journal.pone.0040144.g002
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Recent observations suggest the possible involvement of ER
stress in several types of diseases, including neurodegenerative
disorders, diabetes, obesity and cancer. However, the molecular
regulatory mechanisms of ER stress are not fully understood. In
the present study, we found CK2 to play a key role in regulating
stress, which perturbs ER function.
Considering the linkage of XBP-1 on GRP78 induction,
XBP1(s) was shown to induce GRP78 induction, as transfecting
XBP-1 (s) plasmid increased GRP78 expression in HeLa cells [6].
However, tunicamycin-induced GRP78 expression was only
modestly reduced in XBP-1-deficient MEF [20]. Therefore,
contribution of XBP-1 on GRP78 induction under ER stressed-
condition would be small. On the other hand, GRP78 expression
was shown to be entirely ATF6a dependent [21]. In the present
study, although the linkage of XBP-1 on GRP78 is small under ER
stress [20], we found significant inhibition of both of the UPR
component, i.e.; XBP-1 and GRP78, by inhibiting CK2.
Moreover, although ATF6 processing was not affected by CK2
inhibitor, GRP78 was significantly inhibited in SH-SY5Y cells. So
how would a modest effect on XBP1 splicing turn into a similar
degree difference in GRP78 expression when ATF6 processing is
intact? The reasons for these observations are at present unknown,
but as CK2 has multiple substrates [22], it is possible that CK2
would affect other unknown UPR regulatory factor, which would
affect GRP78 induction. ERdj4 is known to be regulated through
XBP-1 under ER stressed condition [20]. In the preliminary study,
as shown in the Figure S1, we found that ERdj4 was induced by
ER stress in the primary cultured glial cells (Figure S1), suggesting
that XBP-1 splicing may be functional in the glial cells. It would
thus be interesting to investigate whether CK2 would affect ERdj4
similarly with XBP1 splicing and GRP78.
The involvement of CK2 in the control of UPR signaling is
surprising and points to a novel mechanism for the regulation of
ER stress under physiological conditions. For instance, CK2 would
function to regulate immune reactions by connecting the cellular
response to ER stress to inflammatory signaling. CK2 and p38
MAP kinase were shown to directly interact in response to TNFa
[13], which itself can also activate UPR [23]. On the other hand,
p38 MAP kinase phosphorylated a spliced form of XBP-1 at the
residues Thr48 and Ser61, which subsequently enhanced its
nuclear migration [24]. XBP-1 was shown to induce interleukin
(IL)-6 expression [25]. We found that CK2 can activate ER stress-
induced activation of XBP-1 splicing. Therefore, we can speculate
from these observations that CK2 and XBP-1 would associate
each other to regulate immune functions.
The present results may also have implications for the
development of Alzheimer’s disease (AD). Several reports indicate
the involvement of CK2 in the pathology of AD. It was reported
that spermine-dependent CK2 activity was reduced by 84% and
the amount of CK2 was reduced by 63% in the AD brain [26].
Amyloid b-protein stimulates CK2 activity, which would contrib-
ute to abnormal protein phosphorylation in the AD brain [27]. On
the other hand, ER stress has been suggested to be involved in the
pathology of AD in glial as well as neuronal cells [14,28,29]. These
observations combined with the present result suggest the possible
link between CK2 and ER stress with respect to AD.
Figure 3. The CK2 inhibitor inhibited ER stress-induced XBP-1 mRNA splicing. (A) Primary cultured glial cells were pre-treated with 4,5,6,7-
tetrabromobenzotriazole (TBB: 5 mM) for 3 h, treated with tunicamycin (Tm: 0.01 mg/mL) or thapsigargin (Tg: 0.01 mM) for 6 h, and subjected to a RT-
PCR analysis. (B) Densitometric analysis of spliced/unspliced XBP-1 mRNA. An ER stress inducer increased XBP-1 splicing and this effect was
significantly inhibited by TBB. n=4–5/group *p,0.05 compared with ER stress (Tm, Tg) alone (C) Densitometric analysis of total XBP-1 mRNA
(unspliced and spliced XBP-1 mRNA). n=5/group. TBB did not affect the XBP-1 transcript. Results are expressed as the means 6 S.E.
doi:10.1371/journal.pone.0040144.g003
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mechanisms of ER stress; i.e. a key role for CK2 in regulating
the XBP-1-GRP78 branch of UPR. By regulating such responses,
cells would cope with stress. These basic responses would have
important implications for regulating physiological events such as
immune reactions, cell survival and cell death. Accumulating
evidence has been suggested that neuron-glia communication to
play an important role in the maintenance of normal CNS
function. Therefore, it would be an important future subject to
understand the role of CK2 on glial as well as neuronal cell
function at the ER stressed condition. Furthermore, CK2 would
also play a key role in the development of ER stress-related
diseases such as neurodegenerative disorders, diabetes, obesity and
cancer. Therefore, pharmacological manipulation of CK2 activity
would be useful for treatments. Indeed, the use of CK2 inhibitors
has been suggested to be useful for cancer therapy [30,31].
Interestingly, an increased level of GRP78 expression was
observed in tumors [32]. Therefore, targeting CK2 would inhibit
the UPR activated in cancer cells, and be a new approach to
treatment. Further understanding of the basic mechanism could be
critical for unraveling the molecular mechanism/pharmacological
treatment of ER stress-related disorders.
Materials and Methods
Materials
Tunicamycin (Tm) and thapsigargin (Tg) were obtained from
Wako Pure Chemical Ltd. (Japan). 4,5,6,7-tetrabromobenzotria-
zole (TBB) [18] was obtained from Calbiochem.
Preparation of Primary Cultured Glial Cells
Glial cells were prepared from the whole brains of neonatal
C57BL/6 mice as described previously [33]. The cells were
allowed to grow to confluence (10 days) in DMEM medium
Figure 4. Knocking down CK2 inhibited ER stress-induced XBP-
1 splicing. CK2 siRNA decreased ER stress-induced XBP-1 splicing
compared with control siRNA. Primary cultured glial cells were
transfected with 75 nM siRNA and treated with tunicamycin (Tm:
0.01 mg/mL) for 4 h. A RT-PCR analysis was then performed. n=3/
group. Results are expressed as the means 6 S.E.
doi:10.1371/journal.pone.0040144.g004
Figure 5. The CK2 inhibitor did not affect the eIF2a-CHOP arm of the ER stress-induced UPR. (A) Primary cultured glial cells were pre-
treated with 4,5,6,7-tetrabromobenzotriazole (TBB: 5 mM) for 3 h and treated with tunicamycin (Tm: 0.01 mg/mL) or thapsigargin (Tg: 0.01 mM) for
4 h. Western blotting was then performed. TBB did not affect ER stress-induced eIF2a phosphorylation. Densitometric analysis of the normalization
data of the phospho-eIF2a and eIF2a intensities were done. n=3 per group. (B) Primary cultured glial cells were pre-treated with 4,5,6,7-
tetrabromobenzotriazole (TBB: 5 mM) for 3 h and treated with tunicamycin (Tm: 0.01 mg/mL) or thapsigargin (Tg: 0.01 mM) for 6 h. A RT-PCR analysis
was then performed. n=3/group TBB did not affect ER stress-induced CHOP mRNA expression. (C) Primary cultured glial cells were pre-treated with
4,5,6,7-tetrabromobenzotriazole (TBB: 5 mM) for 3 h and treated with tunicamycin (Tm: 0.01 mg/mL) or thapsigargin (Tg: 0.01 mM) for 18 h. Western
blotting was then performed. n=4/group TBB did not affect ER stress-induced CHOP protein production. Results are expressed as the means 6 S.E.
doi:10.1371/journal.pone.0040144.g005
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streptomycin. All cultured cells were kept at 37uCi n5 %C O 2/
95% air. Subsequently, mixed glial cells were shaken at
120 rpm for 18 h, cultured again for 4 to 6 days in 35 mm
dishes, and then used in the following experiments. At this
point, astrocyte cultures were routinely .95% positive for glial
fibrillary acidic protein, and , 3% of the cells were microglia,
based on positive ED1 (anti-macrophage/microglia monoclonal
antibody) staining.
Ethics Statement. Animal experiments were carried out in
accordance with the NIH Guide for Care and Use of Laboratory
Animals and approved by the animal care and use committee at
Hiroshima University (Permit number: A10–41).
RNAi Experiment
Transient transfections of siRNAs were performed in 60–70%
confluent primary cultured glial cells. Lipofectamine
TM 2000 (Life
technologies) was used to transfect siRNA according to the
manufacturer’s directions. Opti-MEM1 medium was used for the
transfection and the final concentrations of siRNA were 75 nM.
CK2 has two isoforms: CK2a and CK2a’. Because of strong
functional overlap between the two isoforms, we simultaneously
knocked down CK2a and CK2a’ using the following siRNA
sequences: CK2a;5 9-AAC AUU GAA UUA GAU CCA CGU
dTdT-39, CK2a’; 59-AAG AUU CUG GAG AAC CUU CGU
dTdT-39. We used siPerfect Negative Control (SIGMA; SP-NEG)
for the control siRNA transfection. Transfection efficiency of
siRNAs for knocking down CK2 was approximately 55%. Cells
were harvested 72 h after the transfection.
Gene Expression Analysis
Total RNA was isolated using TRI Reagent (Sigma-Aldrich, St.
Louis, MO, USA). Reverse transcriptase-polymerase chain re-
action (RT-PCR) was performed as described previously [34].
cDNA was synthesized from 2 mg of total RNA by reverse
transcription using 25 U of Superscript Reverse Transcriptase
(Invitrogen) and 0.25 mg of Oligo(dt)12–18 primer (Invitrogen) in
a 20-ml reaction mixture containing First-Strand Buffer (Invitro-
gen), 1 mM dNTP mix, 10 mM DTT, and 20 U of RNaseOUT
Recombinant Ribonuclease Inhibitor (Invitrogen). Total RNA and
the Oligo (dt) 12–18 primer were pre incubated at 70uC for
10 min prior to the reverse transcription. After incubation for
1.5 h at 46uC, the reaction was terminated by incubating samples
for 15 min at 70uC. For PCR amplification, 1.2 ml of cDNA was
added to 10.8 ml of a reaction mix containing 0.2 mM of each
primer, 0.2 mM of dNTP mix, 0.6 U of Taq polymerase (Roche
Diagnostics), and reaction buffer. PCR was performed in a DNA
Thermal Cycler (MJ Research, PTC-220). The following primer
Figure 6. CK2 inhibitor did not affect ER stress-induced ATF6 processing. (A) SH-SY5Y cells were pre-treated with 4,5,6,7-
tetrabromobenzotriazole (TBB: 5 mM) for 3 h, and then treated with thapsigargin (Tg: 10 mM) for 18 h and Western blotting analysis was performed.
TBB inhibited ER stress-induced GRP78 expression. *p,0.05 (B) SH-SY5Y cells were pre-treated with 4,5,6,7-tetrabromobenzotriazole (TBB: 5 mM) for
3 h, and then treated with thapsigargin (Tg: 10 mM) for 4 h and Western blotting analysis was performed using ATF6 antibody. (C) Densitometric
analysis of p90ATF6. (D) Densitometric analysis of p50 ATF6. TBB did not affect ER stress-induced ATF6 cleavage. n=2–3/group. Results are expressed
as the means 6 S.E.
doi:10.1371/journal.pone.0040144.g006
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acg g-39, and downstream, 59-gca tcc tgg tgg ctt cca gcc att c-39,
CHOP; upstream, 59–ccc tgc ctt tca cct tgg-39, and downstream,
59-ccg ctc gtt ctc ctg ctc-39, XBP-1; upstream, 59–cct tgt ggt tga
gaa cca gg-39, and downstream, 59-cta gag gct tgg tgt ata c-39,
GAPDH; upstream, 59-aaa ccc atc acc atc ttc cag-39 and
downstream, 59-agg ggc cat cca cag tct tct-39. The PCR products
(10 ml) were resolved by electrophoresis in an 8% polyacrylamide
gel in TBE buffer. The gel was stained with ethidium bromide and
photographed under ultraviolet light. Each bands of the density
was measured using Image J 1.37v (Wayne Rasband, NIH)
software.
Western Blotting
Cells were washed with ice cold PBS and lysed in a buffer
containing 10 mM HEPES-NaOH (pH 7.5), 150 mM NaCl,
1 mM EGTA, 1 mM Na3VO4, 10 mM NaF, 10 mg/ml aprotinin,
10 mg/ml leupeptin, 1 mM PMSF, and 1% NP-40 for 20 min.
The lysates were centrifuged at 15,000 rpm for 20 min at 4uC,
and the supernatants were collected. The samples were boiled with
laemmli buffer for 3 min, fractionated by SDS-PAGE, and
transferred at 4uC to nitrocellulose membranes. The membranes
were incubated with anti-KDEL (StressGen; diluted to 1:1,000),
anti-CHOP (Santa Cruz; diluted to 1:500), anti-phospho (Ser51)-
eIF2a (Cell Signaling; diluted to 1:1,000), anti- eIF2a (Santa Cruz;
diluted to 1:1,000), anti-ATF6 (Santa Cruz; diluted to 1:1,000),
anti-CK2 (Santa Cruz; diluted to 1:1,000) and anti-GAPDH
(Chemicon; diluted to 1:2000) antibodies followed by anti-
horseradish peroxidase-linked antibody. Peroxidase was detected
by chemiluminescence using an ECL system.
Immunohistochemistry
Cells were fixed with methanol for 10 minutes at 220uC.
After being washed with PBS, the cells were incubated with 5%
normal bovine serum at 37uC for 1 h, and allowed to react with
anti-CK2 (Santa Cruz; diluted to 1:100) and anti-KDEL
(StressGen; diluted to 1:100) antibodies at 4uC overnight. The
cells were then incubated with anti-goat immunoglobulin G
antibody conjugated with Alexa 546 (1:2000) and anti-mouse
immunoglobulin G antibody conjugated with Alexa 488 (1:2000)
at 37uC for 1 h. The cells were visualized using confocal laser
scanning microscopy. The confocal laser scanning microscopy
was carried out at the Analysis Center of Life Science, Natural
Science Center for Basic Research and Development, Hir-
oshima University.
Figure 7. ER stress did not affect expression of CK2. (A) Primary
cultured glial cells were treated with tunicamycin (Tm: 0.01 mg/mL) or
thapsigargin (Tg: 0.01 mM) for 18 h and subjected to Western blotting.
ER stress increased GRP78 levels whereas it did not affect levels of CK2.
(B) Densitometric analysis of expression of CK2. n=4/group. Results are
expressed as the means 6 S.E.
doi:10.1371/journal.pone.0040144.g007
Figure 8. Existence of CK2 at the endoplasmic reticulum. Primary cultured glial cells were immunostained for anti-CK2 (left, red) and anti-KDEL
(A marker of ER; middle, green) antibodies, respectively. The right panel is a merged image of the left and middle panels. Scale bar, 10 mm.
doi:10.1371/journal.pone.0040144.g008
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Results are expressed as the means 6 S.E. Statistical analysis
was performed using Student’s t-test or paired t-test.
Supporting Information
Figure S1 Primary cultured glial cells were treated with
tunicamycin (Tm: 1 mg/mL) for 5 h, and subjected to
RT-PCR analysis. ERdj4 levels were significantly increased by
ER stress. n=6/group **p,0.01 compared with ER stress (Tm)
alone. Results are expressed as the means 6 S.E. ERdj4 specific
primer pair: upper 59-GCT GTG GAG AAG CTG CGT CGG-
39, lower 59- ATC CTG GCG TGT GTG GAA GTG G-39.
(TIF)
Acknowledgments
We thank Hiroyuki Takeda for the help with confocal microscopy.
Author Contributions
Conceived and designed the experiments: TH KO. Performed the
experiments: TH KK NH TS. Analyzed the data: TH KK NH TS YO
YN KO. Wrote the paper: TH.
References
1. Mori K (2000) Tripartite management of unfolded proteins in the endoplasmic
reticulum. Cell 101: 451–454.
2. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum
unfolded protein response. Nat. Rev. Mol. Cell Biol. 8: 519–529.
3. Hosoi T, Ozawa K (2010) Endoplasmic reticulum stress in disease: mechanisms
and therapeutic opportunities. Clin. Sci. (Lond). 118: 19–29.
4. Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic
reticulum: coordination of gene transcriptional and translational controls. Genes
Dev. 13: 1211–1233.
5. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, et al. (2002) IRE1 couples
endoplasmic reticulum load to secretory capacity by processing the XBP-1
mRNA. Nature 415: 92–96.
6. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001) XBP1 mRNA is
induced by ATF6 and spliced by IRE1 in response to ER stress to produce
a highly active transcription factor. Cell 107: 881–891.
7. Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are
coupled by an endoplasmic-reticulum-resident kinase. Nature 397: 271–274.
8. Shi Y, Vattem KM, Sood R, An J, Liang J, et al. (1998) Identification and
characterization of pancreatic eukaryotic initiation factor 2 a-subunit kinase,
PEK, involved in translational control. Mol. Cell Biol. 18: 7499–7509.
9. Harding HP, Novoa I, Zhang Y, Zeng H, Wek RC, et al. (2000) Regulated
translation initiation controls stress-induced gene expression in mammalian cells.
Mol. Cell 6: 1099–1108.
10. Ahmed K, Gerber DA, Cochet C (2002) Joining the cell survival squad: an
emerging role for protein kinase CK2. Trends Cell Biol. 12: 226–230.
11. Blaydes JP, Hupp TR (1998) DNA damage triggers DRB-resistant phosphor-
ylation of human p53 at the CK2 site. Oncogene 17: 1045–1052.
12. Gerber DA, Souquere-Besse S, Puvion F, Dubois MF., Bensaude O, et al. (2000)
Heat-induced relocalization of protein kinase CK2. Implication of CK2 in the
context of cellular stress. J. Biol. Chem. 275: 23919–23926.
13. Sayed M, Kim SO, Salh BS, Issinger OG, Pelech SL (2000) Stress-induced
activation of protein kinase CK2 by direct interaction with p38 mitogen-
activated protein kinase. J. Biol. Chem. 275: 16569–16573.
14. Hosoi T, Hyoda K, Okuma Y, Nomura Y, Ozawa K (2007) Akt up- and down-
regulation in response to endoplasmic reticulum stress. Brain Res. 1152: 27–31.
15. Hosoi T, Sasaki M, Baba S, Ozawa K (2009) Effect of pranoprofen on
endoplasmic reticulum stress in the primary cultured glial cells. Neurochem Int.
54: 1–6.
16. Hosoi T, Kume A, Otani K, Oba T, Ozawa K (2010) A unique modulator of
endoplasmic reticulum stress-signalling pathways: the novel pharmacological
properties of amiloride in glial cells. Br. J. Pharmacol. 159: 428–437.
17. Kondo S, Murakami T, Tatsumi K, Ogata M, Kanemoto S, et al. (2005)
OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes.
Nat Cell Biol. 7: 186–194.
18. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, et al. (2001) Selectivity of
4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein
kinase CK2 (‘casein kinase-2’). FEBS Lett. 496: 44–48.
19. Faust M, Jung M, Gu ¨nther J, Zimmermann R, Montenarh M (2001)
Localization of individual subunits of protein kinase CK2 to the endoplasmic
reticulum and to the Golgi apparatus. Mol. Cell. Biochem. 227: 73–80.
20. Lee AH, Iwakoshi NN, Glimcher LH (2003) XBP-1 regulates a subset of
endoplasmic reticulum resident chaperone genes in the unfolded protein
response. Mol. Cell Biol. 23: 7448–7459.
21. Yamamoto K, Sato T, Matsui T, Sato M, Okada T, et al. (2007) Transcriptional
induction of mammalian ER quality control proteins is mediated by single or
combined action of ATF6a and XBP1. Dev. Cell 13: 365–376.
22. Meggio F, Pinna LA (2003) One-thousand-and-one substrates of protein kinase
CK2? FASEB J. 17: 349–368.
23. Xue X, Piao JH, Nakajima A, Sakon-Komazawa S, Kojima Y, et al. (2005)
Tumor necrosis factor a (TNFa) induces the unfolded protein response (UPR) in
a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts
ROS accumulation by TNFa. J. Biol. Chem. 280: 33917–33925.
24. Lee J, Sun C, Zhou Y, Lee J, Gokalp D, et al. (2011) p38 MAPK-mediated
regulation of Xbp1s is crucial for glucose homeostasis. Nat. Med. 17: 1251–
1260.
25. Iwakoshi NN, Lee AH, Vallabhajosyula P, Otipoby KL, Rajewsky K, et al.
(2003) Plasma cell differentiation and the unfolded protein response intersect at
the transcription factor XBP-1. Nat. Immunol. 4: 321–329.
26. Iimoto DS, Masliah E, DeTeresa R, Terry RD, Saitoh T (1990) Aberrant casein
kinase II in Alzheimer’s disease. Brain Res. 507: 273–280.
27. Chauhan A, Chauhan VP, Murakami N, Brockerhoff H, Wisniewski HM (1993)
Amyloid beta-protein stimulates casein kinase I and casein kinase II activities.
Brain Res. 629: 47–52.
28. Hosoi T, Tamubo T, Horie N, Okuma Y, Nomura Y, et al. (2010) TEK/Tie2 is
a novel gene involved in endoplasmic reticulum stress. J Pharmacol. Sci. 114:
230–233.
29. Lindholm D, Wootz H, Korhonen L (2006) ER stress and neurodegenerative
diseases. Cell Death Differ. 13: 385–392.
30. Trembley JH, Chen Z, Unger G, Slaton J, Kren BT, et al. (2010) Emergence of
protein kinase CK2 as a key target in cancer therapy. Biofactors 36: 187–195.
31. Ahmad KA, Wang G, Slaton J, Unger G, Ahmed K (2005) Targeting CK2 for
cancer therapy. Anticancer Drugs 16: 1037–1043.
32. Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, et al. (2003) Activation
of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma:
a possible involvement of the ER stress pathway in hepatocarcinogenesis. J.
Hepatol. 38: 605–614.
33. Hosoi T, Okuma Y, Nomura Y (2000) Expression of leptin receptors and
induction of IL-1b transcript in glial cells. Biochem. Biophys. Res. Commun.
273: 312–315.
34. Hosoi T, Sasaki M, Miyahara T, Hashimoto C, Matsuo S, et al. (2008)
Endoplasmic reticulum stress induces leptin resistance. Mol. Pharmacol. 74:
1610–1609.
CK2 Regulates the XBP-1-GRP78 Arm of UPR
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e40144